HCA Healthcare (NYSE:HCA – Get Free Report) had its price objective lifted by equities researchers at JPMorgan Chase & Co. from $425.00 to $475.00 in a research note issued on Wednesday, Benzinga reports. The brokerage presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s target price suggests a potential upside of 3.14% from the company’s current price.
Several other equities analysts have also weighed in on the company. TD Cowen lifted their price target on HCA Healthcare from $460.00 to $486.00 and gave the company a “buy” rating in a research note on Wednesday, October 28th. UBS Group lowered their price target on HCA Healthcare from $635.00 to $579.00 and set a “buy” rating on the stock in a research report on Monday, July 27th. Cantor Fitzgerald restated an “overweight” rating on shares of HCA Healthcare in a research report on Friday, October 2nd. Mizuho set a $495.00 target price on HCA Healthcare in a research note on Wednesday, October 28th. Finally, Wells Fargo & Company increased their target price on HCA Healthcare from $381.00 to $468.00 and gave the company an “equal weight” rating in a research report on Monday, November 2nd. Sixteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and an average target price of $482.30.
Get Our Latest Research Report on HCA Healthcare
HCA Healthcare Stock Performance
HCA Healthcare (NYSE:HCA – Get Free Report) last released its quarterly earnings data on Tuesday, October 27th. The company reported $7.22 earnings per share for the quarter, beating analysts’ consensus estimates of $6.65 by $0.57. HCA Healthcare had a net margin of 8.61% and a negative return on equity of 198.52%. The company had revenue of $19.85 billion during the quarter, compared to analysts’ expectations of $19.33 billion. During the same quarter in the previous year, the company earned $6.96 earnings per share. The firm’s revenue for the quarter was up 3.6% on a year-over-year basis. On average, equities analysts expect that HCA Healthcare will post 30.14 EPS for the current year.
Insider Buying and Selling at HCA Healthcare
In related news, COO Jon M. Foster sold 21,713 shares of the business’s stock in a transaction that occurred on Friday, November 6th. The stock was sold at an average price of $494.95, for a total transaction of $10,746,849.35. Following the completion of the sale, the chief operating officer directly owned 10,000 shares in the company, valued at approximately $4,949,500. The trade was a 68.47% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Michael J. Schlosser sold 1,200 shares of the stock in a transaction dated Wednesday, November 4th. The shares were sold at an average price of $494.65, for a total transaction of $593,580.00. Following the completion of the sale, the executive vice president owned 1,443 shares of the company’s stock, valued at $713,779.95. This trade represents a 45.40% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 36,413 shares of company stock valued at $18,251,464 over the last quarter. 1.50% of the stock is currently owned by insiders.
Hedge Funds Weigh In On HCA Healthcare
Several large investors have recently modified their holdings of the business. BlackRock Inc. purchased a new stake in shares of HCA Healthcare in the 2nd quarter valued at $5,069,974,000. Legal & General Group Plc purchased a new stake in HCA Healthcare during the second quarter worth about $410,992,000. Jupiter Topco LLC purchased a new position in shares of HCA Healthcare in the second quarter valued at approximately $371,138,000. Wellington Management Group LLP grew its holdings in shares of HCA Healthcare by 20.5% in the second quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company’s stock valued at $1,835,397,000 after purchasing an additional 799,761 shares in the last quarter. Finally, Bank of America Corp DE purchased a new stake in HCA Healthcare during the 2nd quarter worth approximately $238,457,000. Institutional investors and hedge funds own 62.73% of the company’s stock.
About HCA Healthcare
HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine. The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices. Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.
Further Reading
- Five stocks we like better than HCA Healthcare
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
